Evidence map›Paper›PMID 24349374›Full record

ArticlePloS one2013

Mipu1, a novel direct target gene, is involved in hypoxia inducible factor 1-mediated cytoprotection.

Kangkai Wang, Jian Lei, Jiang Zou, Hui Xiao, Anlan Chen, Xiaoliu Liu, Ying Liu, Lei Jiang, Zihui Xiao, Xianzhong Xiao

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Myocardial ischemic preconditioning upregulated protein 1(Mipu1):zinc finger protein 667 - a multifunctional KRAB/C2H2 zinc finger protein.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2015
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Kangkai WangDepartment of Pathophysiology, Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
Jian LeiDepartment of Pathophysiology, Xiangya School of Medicine, Central South University, Changsha, Hunan, China ; Department of Pathology, the Affiliated Tumor Hospital, Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
Jiang ZouDepartment of Pathophysiology, Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
Hui XiaoDepartment of Pathophysiology, Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
Anlan ChenDepartment of Pathophysiology, Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
Xiaoliu LiuDepartment of Pathophysiology, Xiangya School of Medicine, Central South University, Changsha, Hunan, China ; Department of Endocrinology, the Second Xiangya hospital, Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
Ying LiuDepartment of Pathophysiology, Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
Lei JiangDepartment of Pathophysiology, Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
Zihui XiaoDepartment of Pathophysiology, Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
Xianzhong XiaoDepartment of Pathophysiology, Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mipu1 (myocardial ischemic preconditioning up-regulated protein 1), recently identified in our lab, is a novel zinc-finger transcription factor which is up-regulated during ischemic preconditioning. However, it is not clear what transcription factor contributes to its inducible expression. In the present study, we reported that HIF-1 regulates the inducible expression of Mipu1 which is involved in the cytoprotection of HIF-1α against oxidative stress by inhibiting Bax expression. Our results showed that the inducible expression of Mipu1 was associated with the expression and activation of transcription factor HIF-1 as indicated by cobalt chloride (CoCl2) treatment, HIF-1α overexpression and knockdown assays. EMSA and luciferase reporter gene assays showed that HIF-1α bound to the hypoxia response element (HRE) within Mipu1 promoter region and promoted its transcription. Moreover, our results revealed that Mipu1 inhibited the expression of Bax, an important pro-apoptosis protein associated with the intrinsic pathway of apoptosis, elevating the cytoprotection of HIF-1 against hydrogen peroxide (H2O2)-mediated injury in H9C2 cells. Our findings implied that Bax may be a potential target gene of transcription factor Mipu1, and provided a novel insight for understanding the cytoprotection of HIF-1 and new clues for further elucidating the mechanisms by which Mipu1 protects cell against pathological stress.

Indexed as

Animalsbcl-2-Associated X ProteinCell LineCobaltGene ExpressionGene Expression RegulationGenes, ReporterHypoxiaHypoxia-Inducible Factor 1, alpha SubunitNuclear ProteinsOxidative StressPromoter Regions, GeneticProtein BindingRatsRepressor ProteinsRNA Interferencebcl-2-Associated X ProteinCobaltcobaltous chlorideHypoxia-Inducible Factor 1, alpha SubunitMipu1 protein, ratNuclear ProteinsRepressor Proteins

Identifiers

PMID24349374
PMCPMC3859620
OpenAlexW2010603984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.